FibroGen

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FibroGen and other ETFs, options, and stocks.

About FGEN

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer.

CEO

Thane Wettig

CEOThane Wettig

Employees

225

Employees225

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

1993

Founded1993

Employees

225

Employees225

FGEN Key Statistics

Market cap

33.08M

Market cap33.08M

Price-Earnings ratio

-0.61

Price-Earnings ratio-0.61

Dividend yield

—

Dividend yield—

Average volume

522.97K

Average volume522.97K

High today

$0.339

High today$0.339

Low today

$0.2912

Low today$0.2912

Open price

$0.2951

Open price$0.2951

Volume

957.89K

Volume957.89K

52 Week high

$1.74

52 Week high$1.74

52 Week low

$0.18

52 Week low$0.18

People also own

Based on the portfolios of people who own FGEN. This list is generated using Robinhood data, and it’s not a recommendation.